Creative Planning’s Asterias Biotherapeutics Warrants AST.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-126
Closed – – 4718
2017
Q2
$0 Sell
126
-5
-4% -$2 ﹤0.01% 5115
2017
Q1
$0 Buy
131
+3
+2% +$1 ﹤0.01% 5176
2016
Q4
$0 Buy
128
+20
+19% +$11 ﹤0.01% 5129
2016
Q3
$0 Sell
108
-4
-4% -$1 ﹤0.01% 4970
2016
Q2
$0 Buy
+112
New +$58 ﹤0.01% 4780

Creative Planning's AST.WS Position: Q3 2017 in Review

Creative Planning sold out of Asterias Biotherapeutics Warrants (AST.WS) in Q3 2017, closing a stake of 126 shares.

Creative Planning first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • Creative Planning reported no remaining Asterias Biotherapeutics Warrants position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 126 Asterias Biotherapeutics Warrants shares in Q3 2017.
  • Creative Planning first reported a position in Asterias Biotherapeutics Warrants in Q2 2016 and held it in 5 quarters.
  • Creative Planning's Asterias Biotherapeutics Warrants position peaked at $0 in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Warrants as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.